lusutrombopag 3 MG Oral Tablet

RxCUI: 2054989
RxNorm name: lusutrombopag 3 MG Oral Tablet
Display name: lusutrombopag 3 MG Oral Tablet
Full name: lusutrombopag 3 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mulpleta	LUSUTROMBOPAG	VANCOCIN ITALIA SRL	a390aec3-6e77-45f8-95d3-d4b8c2eeee40	2025-12-09	Warnings, Adverse reactions	Exact identifier rxcui: 2054989
Mulpleta	LUSUTROMBOPAG	Eddingpharm (U. S. ) Inc.	3f6b72db-3abc-4169-9bee-8dc3078357e6	2025-11-24	Warnings, Adverse reactions	Exact identifier rxcui: 2054989
Mulpleta	LUSUTROMBOPAG	SHIONOGI INC.	f9fd0cfd-717d-4a87-99bc-de7b38807e55	2020-10-29	Warnings, Adverse reactions	Exact identifier rxcui: 2054989

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f9fd0cfd-717d-4a87-99bc-de7b38807e55	lusutrombopag 3 MG Oral Tablet [PSN] · lusutrombopag 3 MG Oral Tablet [SCD]	2	7	These highlights do not include all the information needed to use MULPLETA safely and effectively. See full prescribing information for MULPLETA. MULPLETA ® (lusutrombopag tablets) for oral use Initial U.S. Approval: 2018	20201029
a390aec3-6e77-45f8-95d3-d4b8c2eeee40	lusutrombopag 3 MG Oral Tablet [PSN] · lusutrombopag 3 MG Oral Tablet [SCD]	2	6	These highlights do not include all the information needed to use MULPLETA safely and effectively. See full prescribing information for MULPLETA. MULPLETA ® (lusutrombopag tablets) for oral use Initial U.S. Approval: 2018	20251209
3f6b72db-3abc-4169-9bee-8dc3078357e6	lusutrombopag 3 MG Oral Tablet [PSN] · lusutrombopag 3 MG Oral Tablet [SCD]	2	3	These highlights do not include all the information needed to use MULPLETA safely and effectively. See full prescribing information for MULPLETA. MULPLETA ® (lusutrombopag tablets) for oral use Initial U.S. Approval: 2018	20251124